Update and interpretation of the European LeukemiaNet guideline for the diagnosis and treatment of acute myeloid leukemia in 2022
10.3760/cma.j.cn115356-20220810-00230
- VernacularTitle:2022年欧洲白血病网络急性髓系白血病诊治指南更新要点解读
- Author:
Shanglong FENG
1
;
Changcheng ZHENG
Author Information
1. 中国科学技术大学附属第一医院（安徽省立医院）血液科，合肥 230001
- Keywords:
Leukemia, myeloid, acute;
European LeukemiaNet;
Guideline
- From:
Journal of Leukemia & Lymphoma
2022;31(11):641-643
- CountryChina
- Language:Chinese
-
Abstract:
The 2010 and 2017 editions of the European LeukemiaNet (ELN) guideline for the diagnosis and treatment of acute myeloid leukemia (AML) have been widely used in clinical practice. With further understanding of the molecular biological mechanisms of AML and tremendous progress in the application of clinically targeted drugs, the 2022 edition ELN AML guidelines were recently published online in the Blood. The article interprets the updated key points of the guideline.
